Medical Cannabis
Legal Medical Cannabis Means Better, Not Weaker, Health Protection
Dr. Julian Wichmann, MD, Co-Founder and CEO of Bloomwell GmbH Germany has, without question, the most progressive regulation of medical cannabis in the EU.
Opinion
Read expert opinions and analysis on policy, markets, and culture in the cannabis industry.
169stories
26 Octlast updated
More in Opinion
- Cultivation
What APAC Producers Get Wrong About EU-GMP
Written by Dr Nickel Dittrich, Managing Director, GMPion When Asia-Pacific producers talk about Europe, the conversation usually starts in the grow room.
- M&A Activity
Does Your IP Moat Your Business?
This article was written by Sean McLean, CEO & Co-Founder, Peregrine Precision Systems, and originally published here.
- Cultivation
Are We Underestimating the Pharmaceutical Potential of the Cannabis Plant?
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation and more controlled delivery could help realise it.
- Opinion
Selling US Grown Flower to Europe: What the Margin Actually Says
Written by Michael Sassano, Founder and Interim CEO, SOMAÍ Pharmaceuticals Most US cannabis companies thinking about Europe focus on the wrong number.
- Clinical Research
The science of THCV
Cannabis research has historically concentrated on THC and CBD, and for good reason.
- Opinion
Opinion: New Labour Administration Can End Britain’s Failed Cannabis Experiment
Written by Omar Khan, Chief Communications and Public Affairs Officer, High Tide Inc.
- Opinion
Patients First: What Training the Police Taught Me About Medical Cannabis
As new national guidance instructs officers to treat medical cannabis users as patients first, James Duckenfield, CEO of Glass Pharms, reflects on what training police forces has taught him about the gap between the law and the general understanding of the legal landscape, and how the industry as a whole can help close it.
- Clinical Research
Why Medical Companies Win Rescheduling, Whatever Happens to Adult-Use
This week, what is perhaps the most consequential hearing in the history of the US, and indeed the global cannabis industry, is taking place in Arlington, Virginia.
